Literature DB >> 24481529

Multifaceted roles of miR-1s in repressing the fetal gene program in the heart.

Yusheng Wei1, Siwu Peng2, Meng Wu2, Ravi Sachidanandam3, Zhidong Tu3, Shihong Zhang4, Christine Falce5, Eric A Sobie5, Djamel Lebeche4, Yong Zhao2.   

Abstract

miRNAs are an important class of regulators that play roles in cellular homeostasis and disease. Muscle-specific miRNAs, miR-1-1 and miR-1-2, have been found to play important roles in regulating cell proliferation and cardiac function. Redundancy between miR-1-1 and miR-1-2 has previously impeded a full understanding of their roles in vivo. To determine how miR-1s regulate cardiac function in vivo, we generated mice lacking miR-1-1 and miR-1-2 without affecting nearby genes. miR-1 double knockout (miR-1 dKO) mice were viable and not significantly different from wild-type controls at postnatal day 2.5. Thereafter, all miR-1 dKO mice developed dilated cardiomyopathy (DCM) and died before P17. Massively parallel sequencing showed that a large portion of upregulated genes after deletion of miR-1s is associated with the cardiac fetal gene program including cell proliferation, glycolysis, glycogenesis, and fetal sarcomere-associated genes. Consistent with gene profiling, glycogen content and glycolytic rates were significantly increased in miR-1 dKO mice. Estrogen-related Receptor β (Errβ) was identified as a direct target of miR-1, which can regulate glycolysis, glycogenesis, and the expression of sarcomeric proteins. Cardiac-specific overexpression of Errβ led to glycogen storage, cardiac dilation, and sudden cardiac death around 3-4 weeks of age. We conclude that miR-1 and its primary target Errβ act together to regulate the transition from prenatal to neonatal stages by repressing the cardiac fetal gene program. Loss of this regulation leads to a neonatal DCM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481529      PMCID: PMC3945888          DOI: 10.1038/cr.2014.12

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  59 in total

Review 1.  Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation.

Authors:  Gary D Lopaschuk; Jagdip S Jaswal
Journal:  J Cardiovasc Pharmacol       Date:  2010-08       Impact factor: 3.105

2.  The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth.

Authors:  Jason M Tennessen; Keith D Baker; Geanette Lam; Janelle Evans; Carl S Thummel
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

Review 3.  MicroRNAs in heart development.

Authors:  Ramón A Espinoza-Lewis; Da-Zhi Wang
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 4.  MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment.

Authors:  Daniel Quiat; Eric N Olson
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

5.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

Authors:  Masaki Ieda; Ji-Dong Fu; Paul Delgado-Olguin; Vasanth Vedantham; Yohei Hayashi; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

6.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.

Authors:  Hongli Shan; Xuelian Li; Zhenwei Pan; Li Zhang; Benzhi Cai; Yong Zhang; Chaoqian Xu; Wenfeng Chu; Guofen Qiao; Baoxin Li; Yanjie Lu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

7.  Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.

Authors:  Zenawit Girmatsion; Peter Biliczki; Angelika Bonauer; Gerhard Wimmer-Greinecker; Mirella Scherer; Anton Moritz; Alicia Bukowska; Andreas Goette; Stanley Nattel; Stefan H Hohnloser; Joachim R Ehrlich
Journal:  Heart Rhythm       Date:  2009-09-03       Impact factor: 6.343

8.  Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy.

Authors:  Guillermo Luxán; Jesús C Casanova; Beatriz Martínez-Poveda; Belén Prados; Gaetano D'Amato; Donal MacGrogan; Alvaro Gonzalez-Rajal; David Dobarro; Carlos Torroja; Fernando Martinez; José Luis Izquierdo-García; Leticia Fernández-Friera; María Sabater-Molina; Young-Y Kong; Gonzalo Pizarro; Borja Ibañez; Constancio Medrano; Pablo García-Pavía; Juan R Gimeno; Lorenzo Monserrat; Luis J Jiménez-Borreguero; José Luis de la Pompa
Journal:  Nat Med       Date:  2013-01-13       Impact factor: 53.440

Review 9.  The function of miRNA in cardiac hypertrophy.

Authors:  Jian Wang; Xiao Yang
Journal:  Cell Mol Life Sci       Date:  2012-08-25       Impact factor: 9.261

10.  Mammalian heart renewal by pre-existing cardiomyocytes.

Authors:  Samuel E Senyo; Matthew L Steinhauser; Christie L Pizzimenti; Vicky K Yang; Lei Cai; Mei Wang; Ting-Di Wu; Jean-Luc Guerquin-Kern; Claude P Lechene; Richard T Lee
Journal:  Nature       Date:  2012-12-05       Impact factor: 49.962

View more
  28 in total

Review 1.  The roles of microRNAs in mouse development.

Authors:  Brian DeVeale; Jennifer Swindlehurst-Chan; Robert Blelloch
Journal:  Nat Rev Genet       Date:  2021-01-15       Impact factor: 53.242

Review 2.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

3.  Adipocyte-specific loss of PPARγ attenuates cardiac hypertrophy.

Authors:  Xi Fang; Matthew J Stroud; Kunfu Ouyang; Li Fang; Jianlin Zhang; Nancy D Dalton; Yusu Gu; Tongbin Wu; Kirk L Peterson; Hsien-Da Huang; Ju Chen; Nanping Wang
Journal:  JCI Insight       Date:  2016-10-06

4.  The E3 ubiquitin ligase Nedd4/Nedd4L is directly regulated by microRNA 1.

Authors:  Jun-Yi Zhu; Amy Heidersbach; Irfan S Kathiriya; Bayardo I Garay; Kathryn N Ivey; Deepak Srivastava; Zhe Han; Isabelle N King
Journal:  Development       Date:  2017-03-01       Impact factor: 6.868

Review 5.  MicroRNAs and Cardiac Regeneration.

Authors:  Conrad P Hodgkinson; Martin H Kang; Sophie Dal-Pra; Maria Mirotsou; Victor J Dzau
Journal:  Circ Res       Date:  2015-05-08       Impact factor: 17.367

6.  MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.

Authors:  Qing Chen; Yidong Wang; Huimin Dang; Xiaoling Wu
Journal:  Oncol Lett       Date:  2021-06-24       Impact factor: 2.967

7.  Polymorphism in miRNA-1 target site and circulating miRNA-1 phenotype are associated with the decreased risk and prognosis of coronary artery disease.

Authors:  Lina Wang; Hong Zhi; Yongjun Li; Genshan Ma; Xingzhou Ye; Xiaojin Yu; Tian Yang; Han Jin; Zuhong Lu; Pingmin Wei
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

8.  Inducible degradation of lncRNA Sros1 promotes IFN-γ-mediated activation of innate immune responses by stabilizing Stat1 mRNA.

Authors:  Henan Xu; Yan Jiang; Xiaoqing Xu; Xiaoping Su; Yang Liu; Yuanwu Ma; Yong Zhao; Zhongyang Shen; Bo Huang; Xuetao Cao
Journal:  Nat Immunol       Date:  2019-11-18       Impact factor: 25.606

9.  Evidence that the acetyltransferase Tip60 induces the DNA damage response and cell-cycle arrest in neonatal cardiomyocytes.

Authors:  Xinrui Wang; Carri Lupton; Amelia Lauth; Tina C Wan; Parker Foster; Michaela Patterson; John A Auchampach; John W Lough
Journal:  J Mol Cell Cardiol       Date:  2021-02-18       Impact factor: 5.763

Review 10.  miRNA in cardiac development and regeneration.

Authors:  Zhaohui Ouyang; Ke Wei
Journal:  Cell Regen       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.